PGRN is a well-established modulator of immune function a very relevant physiological process that takes part in cancer, metabolic disease and neurodegeneration (Toh et al., 2011; Cenik et al., 2012; Jian et al., 2013; Tanaka et al., 2013; Kao et al., 2017). The gene discussed is GRN; the disease is cancer.